Franklin Covey (FC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Amendment clarifies voting treatment for Proposal No. 4 at the January 24, 2025 Annual Meeting.
Only the method for counting abstentions and broker non-votes on Proposal No. 4 is affected; all other disclosures remain unchanged.
Voting matters and shareholder proposals
Proposal No. 4 concerns approval of an amendment to the 2022 Omnibus Incentive Plan.
Approval requires more votes cast in favor than against; abstentions and broker non-votes do not affect the outcome.
Shareholders who have already voted need not vote again unless they wish to change their vote.
Shareholder rights and capital structure
Instructions are provided for shareholders wishing to change or revoke their prior vote before the Annual Meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Franklin Covey
- FY25 revenue and profit declined, but FY26 guidance anticipates margin recovery and growth.FC
Q4 202510 Mar 2026 - Q3 revenue, net income, and cash flow rose, with record fiscal 2024 results expected.FC
Q3 20243 Feb 2026 - Strong FY24 results and growth investments set stage for double-digit growth from FY26.FC
Q4 202416 Jan 2026 - Q1 FY25 revenue up 1% to $69.1M; Education led growth, net income fell on higher costs.FC
Q1 202510 Jan 2026 - Q1 revenue fell 7% to $64M, net loss was $3.3M, but FY2026 growth guidance was reaffirmed.FC
Q1 20269 Jan 2026 - Revenue and earnings guidance cut as government headwinds persist, but Education and liquidity strong.FC
Q2 202519 Dec 2025 - Annual meeting to elect directors, approve pay, ratify auditors, and advance ESG priorities.FC
Proxy Filing18 Dec 2025 - Annual meeting covers director elections, pay, auditor, and incentive plan amendment.FC
Proxy Filing1 Dec 2025 - Amendment updates equity compensation plan details and voting instructions for the 2025 meeting.FC
Proxy Filing1 Dec 2025